Mounjaro®
Starting from £179.99/mo
Start journey Learn moreUsing a Mounjaro KwikPen correctly takes about sixty seconds once you know the steps, but the single biggest reason injections go wrong is a misunderstanding of how this pen works compared with a standard syringe. Each KwikPen holds four weekly doses, pre-loaded, and is designed so the needle never needs to be attached before use — yet a question our prescribers hear most weeks is exactly that: "do I need to put the needle on?" The answer is no. The KwikPen has a built-in injection mechanism; what you do attach is a disposable needle cap before each dose. These are prescription-only medicines and every patient's specific instructions (how often to inject, when to increase the dose, and what to do if something feels wrong) come from their prescriber and from the Patient Information Leaflet packed with their treatment.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The biggest misconception surrounding Mounjaro KwikPen instructions is that the device works like a conventional insulin pen, meaning you prime it, dial a dose, and push a plunger. It doesn't. The KwikPen is a fixed-dose, multi-use auto-injector: each press of the button delivers exactly one pre-set dose, and the mechanism does the work for you. There is no dial. There is no dose to select. The strength printed on the pen's label is the dose you will receive, and it was set when the pen was manufactured.
This distinction matters because people who expect to prime the pen sometimes waste a dose by pressing the button before they're ready, or press it partially and then press again, delivering an irregular amount. The KwikPen's button should be pressed once, firmly, at the injection site, and held until the dose is delivered, the window indicator on the pen will confirm this. If you are new to Mounjaro or are moving to a new strength, reading through a full walkthrough of how to use the KwikPen before your first injection can save a lot of confusion.
One more myth worth correcting: you do not need to tap the pen, expel air bubbles, or prime it with a test shot. Those steps apply to insulin pens and syringes, not to the KwikPen format. If you want a concise visual reference to keep to hand, our Mounjaro quick pen instructions page summarises each step in a format that's easy to follow at a glance. Following insulin-pen habits here wastes medicine and introduces unnecessary risk.
Start by checking the pen: confirm the label shows your prescribed strength, look at the liquid through the inspection window (it should be clear and colourless), and check the expiry date. If the liquid looks cloudy or contains particles, do not use that pen and contact your prescriber or pharmacy.
Take the pen out of the fridge and allow it to sit at room temperature for a short period before injecting, the exact window recommended is stated in the Patient Information Leaflet that came with your treatment. Injecting a cold solution is not dangerous, but it is frequently the cause of the stinging discomfort people report in their first few weeks.
Clean the chosen injection site with an alcohol swab and allow the skin to dry completely before proceeding, wet skin can sting and slightly increases the chance of a surface reaction. Attach a fresh needle by screwing the needle cap onto the pen's tip, then remove the outer and inner needle caps. Pinch a fold of skin lightly if you are injecting into the abdomen or thigh, press the needle against the skin at a 90-degree angle, and press the button until you hear a click. Hold for at least five seconds before withdrawing to ensure the full dose has been delivered. Recap the needle using the outer cap only, unscrew it, and place it directly into a sharps container. Never re-use needles: a blunted needle increases injection discomfort and the chance of skin reactions.
More detailed guidance on rotating sites and avoiding injection-site reactions is covered on our Mounjaro injection instructions page.
Some things are expected and normal; others warrant a call to your prescriber. Mild redness, a small raised area, or a brief ache at the injection site in the hours after injecting are common, particularly in the first few weeks, and usually settle without intervention. Rotating sites (never injecting twice in exactly the same spot) is the most effective way to manage this. The NHS medicines page for tirzepatide sets out the full side-effect profile and lists the symptoms that should prompt urgent medical attention.
Stop using the pen and get medical help promptly if you develop a severe, persistent stomach pain that radiates toward your back, with or without vomiting, this can be a sign of pancreatitis, a known but uncommon side effect the MHRA has specifically highlighted for GLP-1 medicines. Signs of a serious allergic reaction (swelling of the face or throat, difficulty breathing, a rapid heartbeat) also require immediate emergency care. For anything else that concerns you about your treatment, our support team is available seven days a week, and your prescriber can review your case at any point.
If you miss an injection, check your Patient Information Leaflet for the specific guidance, in general, if fewer than four days remain before your next scheduled dose, skip the missed one rather than taking two close together. Never adjust your dose or your injection timing without speaking to your prescriber first. Details on what to expect around your second injection are worth reading before that date arrives.
Mounjaro KwikPens should be stored in a refrigerator between 2°C and 8°C, away from the freezer compartment and direct cooling elements. A frozen pen should not be used. Between injections, the pen should have its cap on and should not be stored with a needle attached, leaving a needle in place creates a contamination risk and can affect the remaining doses.
The pen can be kept at room temperature for a limited period if refrigeration is not available, your Patient Information Leaflet states the exact duration and conditions. For anyone travelling with their treatment, understanding Mounjaro's storage rules in full before you leave is worth the ten minutes it takes.
Do not expose the pen to direct sunlight or leave it in a hot car or bag pocket. Do not use the pen if it has been frozen and thawed, dropped from height, or shows any physical damage. If you are uncertain whether a pen is still safe to use, contact your pharmacy rather than risking a compromised dose. Legitimate treatment sourced through a GPhC-registered pharmacy comes with clinical aftercare, that includes answering exactly these kinds of storage and handling questions, any day of the week.
If you're thinking about starting Mounjaro and want to understand the full picture of what treatment involves, our weight-loss treatment overview covers how it fits into a structured approach to weight management. When you're ready, check your eligibility with a free consultation reviewed by a GPhC-registered prescriber.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.